<DOC>
	<DOCNO>NCT02035059</DOCNO>
	<brief_summary>The objective study , early oral glucose tolerance test combine maternal history , condition multiple biomarker analysis use detect gestational diabetes mellitus first trimester ( 12-14 week gestation ) .</brief_summary>
	<brief_title>Predictability Gestational Diabetes Mellitus First Second Trimester</brief_title>
	<detailed_description>It investigator ' aim prospectively examine extend form current 1st trimester screen test detection foetal aneuploidy , order ascertain whether also use detection patient at-risk gestational diabetes mellitus . For purpose investigator include combination new marker multiplex bio-array manner conjunction early oral glucose tolerance test . A nested case-control proteomic analysis perform retrospective manner completion study order develop specific biomarker panel . The primary outcome development gestational diabetes mellitus second third trimester . The secondary endpoint delivery outcome , neonatal morbidity , neonatal mortality , maternal morbidity cost .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>Healthy singleton pregnancy Women least 18 year old guardianship Maternal disease like hypertension , diabetes mellitus chronic disease , know infection like hepatitis human immunodeficiency virus Maternal history hypertensive diseases previous pregnancy prophylactic acetylsalicylate treatment Foetal genetic , chromosomal interventionrequiring morphologic abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Oral Glucose Tolerance Test</keyword>
	<keyword>Fibronectin</keyword>
	<keyword>Adiponectin</keyword>
	<keyword>Copeptin</keyword>
	<keyword>Cortisol</keyword>
</DOC>